Download presentation
Presentation is loading. Please wait.
1
www.escardio.org Published today - Advanced Access European Heart Journal http://eurheartj.oxfordjournals.org/
2
www.escardio.org Classification of Atrial Fibrillation Paroxysmal (usually <48 h)
3
www.escardio.org Time Course and Management of AF
4
www.escardio.org Important Elements of the History
5
www.escardio.org Symptom Scores
6
www.escardio.org Diagnosis / Follow-up Class I Recommendations
7
www.escardio.org Principles of Management
8
www.escardio.org CHA 2 DS 2 -VASc
9
www.escardio.org CHA 2 DS 2 -VASc Thromboembolic Risk Score
10
www.escardio.org Selected OAC Recommendations
11
www.escardio.org Bleeding Risk – HAS-BLED Score
12
www.escardio.org Rate and Rhythm Control
13
www.escardio.org Optimal Rate Control
14
www.escardio.org Optimal Rate Control
15
www.escardio.org Choice of Rate Control Medication
16
www.escardio.org Antiarrhythmic Medication for Rhythm Control
17
www.escardio.org Antiarrhythmic Medication for Rhythm Control
18
www.escardio.org Antiarrhythmic Medication for Rhythm Control
19
www.escardio.org Choice of AAD - Underlying Pathology
20
www.escardio.org Catheter Ablation for Atrial Fibrillation
21
www.escardio.org Indication for LA Catheter Ablation
22
www.escardio.org Ablation when SHD is Present
23
www.escardio.org “Upstream” Therapy Primary Prevention ACE inhibitors, Angiotensin receptor blockers, Aldosterone antagonists Statins, PUFAs Agents Considered:
24
www.escardio.org “Upstream” Therapy – Secondary Prevention
25
www.escardio.org Atrial Fibrillation in Athletes
26
www.escardio.org European Heart Rhythm Association (EHRA); Endorsed by the European Association for Cardio-Thoracic Surgery (EACTS)
Similar presentations
